鼻科学年度回顾:从COVID-19到生物制剂
该综述回顾了过去一年鼻科学的重要发现:嗅觉丧失是COVID-19感染最常见症状之一,一项3563例患者的Meta分析发现自报嗅觉丧失的平均患病率为47%;多项研究显示长期嗅觉减退和嗅觉倒错;COVID-19、上呼吸道感染、外伤和CRSwNP是嗅觉功能障碍最常见原因;CRSwNP的生物制剂治疗展现出前景;2021年诺贝尔生理学或医学奖授予温度与触觉受体的发现;慢性鼻炎新定义被提出,强调内型分型以优化治疗效果。
要点
- 嗅觉丧失是COVID-19感染最常见症状之一,Meta分析3563例患者自报嗅觉丧失平均患病率为47%。
- CRSwNP患者中生物制剂治疗的发展似乎正开启光明前景。
- 慢性鼻炎和鼻窦炎患者的内型分型对优化治疗效果具有重要意义。
核心结论
- 过去一年鼻科学的重要发现包括COVID-19相关嗅觉障碍的高患病率、CRSwNP生物制剂治疗的发展、嗅觉受体机制研究的诺贝尔奖级进展以及慢性鼻炎内型分型的重要性。
研究设计与样本
- 本文为综述,回顾过去一年鼻科学的重要发现,引用了一项纳入3563例患者的Meta分析。
主要发现
- 一项3563例患者的Meta分析发现COVID-19自报嗅觉丧失的平均患病率为47%。
- 多项研究显示COVID-19感染后长期嗅觉减退和嗅觉倒错。
- 除COVID-19和上呼吸道感染外,嗅觉功能障碍最常见原因为外伤和CRSwNP。
- 2021年诺贝尔生理学或医学奖联合授予David Julius和Ardem Patapoutian,表彰其发现温度和触觉受体。
关键数值与推荐
- COVID-19自报嗅觉丧失的平均患病率为47%(基于3563例患者的Meta分析)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We look back at the end of what soon will be seen as an historic year, from COVID-19 to real-world introduction of biologicals influencing the life of our patients. This review describes the important findings in Rhinology over the past year. A large body of evidence now demonstrates loss of sense of smell to be one of the most common symptoms of COVID-19 infection; a meta-analysis of 3563 patients found the mean prevalence of self-reported loss to be 47%. A number of studies have now shown long-term reduced loss of smell and parosmia. Given the high numbers of people affected by COVID-19, even with the best reported recovery rates, a significant number worldwide will be left with severe olfactory dysfunction. The most prevalent causes for olfactory dysfunction, besides COVID-19 and upper respiratory tract infections in general, are trauma and CRSwNP. For these CRSwNP patients a bright future seems to be starting with the development of treatment with biologics. This year the Nobel prize in Medicine 2021 was awarded jointly to David Julius and Ardem Patapoutian for their discoveries of receptors for temperature and touch which has greatly enhanced our understanding of nasal hyperreactivity and understanding of intranasal trigeminal function. Finally, a new definition of chronic rhinitis has been proposed in the last year and we have seen many papers emphasizing the importance of endotyping patients in chronic rhinitis and rhinosinusitis in order to optimise treatment effect.
引用
- Fokkens WJ, Landis BN, Hopkins C, et al. Rhinology in review: from COVID-19 to biologicals. Rhinology. 2021. PMID: 34812433. doi:10.4193/Rhin21.424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。